Page last updated: 2024-10-29

iodixanol and Disease, Pulmonary

iodixanol has been researched along with Disease, Pulmonary in 2 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Research Excerpts

ExcerptRelevanceReference
"Iodixanol is reported to be a safe contrast medium that causes no lung injury when instilled intratracheally."1.31Lodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome. ( den Heeten, GJ; Haitsma, JJ; Kesecioglu, J; Lachmann, B; Schultz, MJ, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fanous, R1
Kashani, H1
Jimenez, L1
Murphy, G1
Paul, NS1
Kesecioglu, J1
Schultz, MJ1
Haitsma, JJ1
den Heeten, GJ1
Lachmann, B1

Other Studies

2 other studies available for iodixanol and Disease, Pulmonary

ArticleYear
Image quality and radiation dose of pulmonary CT angiography performed using 100 and 120 kVp.
    AJR. American journal of roentgenology, 2012, Volume: 199, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Female; Humans; Lung Diseases; Male; Mi

2012
Lodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome.
    The European respiratory journal, 2002, Volume: 19, Issue:5

    Topics: Animals; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Contrast Media; Drug Interactions; Lung D

2002